Journal profile

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis

Publisher: Sage Publications
ISSN1076-0296 | 1938-2723 FormatPrint StatusCurrently indexed

Journal Citation Impact

Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.

Impact Factor
3.43
Citation rate 2.62 752 total citations
h5-index 33 h5 depth signal
Cited share 75.2% 230 of 306
Total citations 752 Citation footprint
Metric signal 2.25 External metric anchor
Self-citation 2.5% 19 self-citations

Citations Trend

Monthly Publications Cadence

Citing Geographic Demographics

China 588
United States 399
Turkey 85
Japan 84
Germany 55

Citing Fields of Research

Hematology 1,102
Cardiology 532
Vascular Disorders 151
Clinical Laboratory Science 120
Oncology 84

Publishing Activity & Reach

Volume, recency, access pattern, and citing-community signals from the journal analytics record.

All-time article footprint 3,533 Articles tracked across the journal lifetime
Indexed publication set 306 230 cited publications
Last 12 months 181 60.3 publications/month
Open access share 100.0% 181 OA publications in the last year
Leading citing country China 588 citing publications
Leading citing field Hematology 1,102 citing publications
Latest tracked publication 13 July 2026 10 recent records available

Coverage & Indexing History

MEDLINE
v5n1, Jan. 1999-
PubMed
v5n1, Jan. 1999-
PMC
Active Coverage
Index medicus
Active Coverage

Research Focus & Classification

Indexed Subjects

Hematology Cardiology

Issuing & Sponsoring Bodies

Contributor
International Academy of Clinical and Applied Thrombosis/Hemostasis

Broad Categories

Vascular Diseases Hematology Cardiology

MeSH Descriptors

Hemostasis Thrombosis

Latest Publications

Recent article records with DOI-first linking and condensed abstracts.

01
Ahmed Elbataa, Ameer Awashra, Ahmed Elazab et al.
Background and PurposeCurrent AHA and ACC guidelines warrant studies comparing direct oral anticoagulant (DOAC) and warfarin for post-myocardial infarction (MI) left ventricular thrombus (LVT). DOAC is increasingly considered due to its ...
07
Muhammad Hassan Waseem, Zain Ul Abideen, Ameer Haider Cheema et al.
Background: Replacing bioprosthetic valves is common but can cause coagulation issues. This study assesses the safety and efficacy of Direct oral anticoagulants (DOACs) versus vitamin K antagonists (VKAs) in bioprosthetic valve procedure...
08
Thanaporn Poohirunkul, Yotsaya Kunlamas, Sarawut Siwamogsatham et al.
Background: There are limited data on the performance of bleeding risk scores in predicting postoperative bleeding in anticoagulated patients undergoing elective non-cardiac surgery. Objectives: To evaluate the predictive accuracy of the...

Bibliographical & Catalog Notes

Title from cover.

Imprint varies.

Also issued online.